Resolute Onyx™ RONYX50015UXRecalls & reported problems
Medtronic, Inc. · STENT RONYX50015UX RESOLUTE ONYX 5.00X15 · Class 3 · Implant
All models of Resolute Onyx (101)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 1
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00643169557307), received between May 22, 2018 and Oct 22, 2021 — classified as 1 death, 5 injuries, 1 malfunction.
The most frequently reported specific device problem is “Inflation Problem” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Inflation Problem2
- Activation, Positioning or Separation Problem1
- Device Dislodged or Dislocated1
- Fracture1
- Leak/Splash1
- Malposition of Device1
Patient problems
- Injury2
- Cardiac Arrest1
- Death1
- Embolism/Embolus1
- Myocardial Infarction1
- No Clinical Signs, Symptoms or Conditions1
- Patient Problem/Medical Problem1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryOct 22, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING THE INDEX PROCEDURE ONE RESOLUTE ONYX DRUG ELUTING STENT WAS IMPLANTED IN THE RCA. APPROXIMATELY 19 MONTHS POST PROCEDURE PATIENT SUFFERED FROM A PULMONARY EMBOLISM. THE EVENT WAS TREATED WITH MEDICATION. PATIENT HAS NOT RECOVERED.
Patient problems: Embolism/Embolus
MAUDE report 12680536 ↗MalfunctionJan 6, 2021Inflation Problem; Inflation Problem
DURING A PROCEDURE, AN ATTEMPT WAS MADE TO USE ONE RESOLUTE ONYX RX CORONARY DRUG ELUTING STENT TO TREAT A LESION. IT WAS REPORTED THAT INFLATION DIFFICULTIES OCCURRED WHEN THE STENT WAS PLACED IN THE PATIENT AND THE BALLOON WOULD NOT INFLATE. AN ATTEMPT WAS MADE TO USE A NEW INFLATION DEVICE BUT THIS DID NOT INFLATE THE DEVICE. THE STENT WAS REMOVED AND ANOTHER STENT WAS USED WITH NO ISSUES. NO PATIENT INJURY WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11122531 ↗DeathSep 28, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING INDEX PROCEDURE, A RESOLUTE ONYX DRUG-ELUTING STENT WAS IMPLANTED IN THE RCA. APPROXIMATELY 21 MONTHS POST PROCEDURE, PATIENT EXPIRED. SPONSOR ASSESSMENT OF EVENT IS UNKNOWN.
Patient problems: Cardiac Arrest; Death
MAUDE report 10592032 ↗InjurySep 3, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
DURING THE INDEX PROCEDURE, ONE RESOLUTE ONYX DES WAS IMPLANTED TO TREAT A LESION. CEC ADJUDICATED THAT THE PATIENT SUFFERED MYOCARDIAL INFARCTION IN THE RCA (TARGET VESSEL).
Patient problems: Myocardial Infarction
MAUDE report 10486901 ↗InjuryFeb 20, 2020Fracture; Fracture
A RESOLUTE ONYX RX CORONARY DRUG-ELUTING STENT WAS IMPLANTED DURING A PROCEDURE. IT IS REPORTED THAT THE STENT FRACTURED, WHICH REQUIRED REPEAT CATHETERISATION AND NEW STENT PLACEMENT.
Patient problems: Injury
MAUDE report 9732030 ↗InjuryAug 19, 2019Malposition of Device; Device Dislodged or Dislocated; Malposition of Device; Device Dislodged or Dislocated
DURING A PROCEDURE A RESOLUTE ONYX RX CORONARY, DRUG ELUTING STENT WAS USED TO TREAT A MODERATELY TORTUOUS, MILDLY CALCIFIED LESION IN THE FIRST OBTUSE MARGINAL ARTERY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES. THE LESION WAS NOT PRE DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED DURING DELIVERY. THE LEFT CIRCUMFLEX CAME OFF AT A 90 DEGREE ANGLE FROM A SHORT LEFT MAIN. IT WAS REPORTED THAT WHILE ATTEMPTING TO ADVANCE THE STENT, THE PROXIMAL STENT WAS MOVING IN AND OUT OF THE 6F GUIDE CATHETER AND THE STENT DISLODGED. THE STENT WAS NOT REMOVED. IT WAS DEPLOYED IN THE PROXIMAL LEFT CIRCUMFLEX WITH A 3.5 X 15 BALLOON, THEN POST DILATED WITH A 4.0 AND 5.0 BALLOON. THE PATIENT IS ALIVE WITH NO OTHER INJURY.
Patient problems: Injury
MAUDE report 8905347 ↗InjuryMay 22, 2018Inflation Problem; Leak/Splash; Activation, Positioning or Separation Problem; Inflation Problem; Leak/Splash; Activation, Positioning or Separation Problem
DURING THE PROCEDURE AN ATTEMPT WAS MADE TO USE ONE RESOLUTE ONYX RX CORONARY DRUG ELUTING STENT TO TREAT A MILDLY TORTUOUS AND NON-CALCIFIED LESION LOCATED IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). THERE WERE NO ABNORMALITIES IN RELATION TO THE ANATOMY. THERE WAS NO DAMAGE NOTED TO THE DEVICE PACKAGING. THERE WERE NO ISSUES WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE DEVICE WAS INSPECTED WITH NO ISSUES NOTED. NEGATIVE PREP WAS PERFORMED WITH NO ISSUES. THE LESION WAS PRE-DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. RESISTANCE WAS NOT ENCOUNTERED WHEN ADVANCING THE DEVICE. EXCESSIVE FORCE WAS NOT USED. IT WAS REPORTED THAT THE BALLOON ONLY HALF DEPLOYED AT NOMINAL PRESSURE (12 ATM) AND AFTER THE BALLOON WAS REMOVED IT WAS NOTED THAT THE STENT ONLY HALF DEPLOYED. THE INFLATION DIFFICULTY WAS NOT DUE TO DUE THE VESSEL MORPHOLOGY. THE SAME INFLATION DEVICE WAS USED WITH OTHER DEVICES PRE AND POST INFLATION DIFFICULTIES. IT WAS REPORTED THAT MULTIPLE NC EUPHORA BALLOON CATHETER DEVICES WERE USED TO FINISH DEPLOYING THE STENT. IT IS ALSO REPORTED THAT MULTIPLE SIZES OF THE NC EUPHORA BALLOON CATHETER WERE UNABLE TO CROSS THE LESION. PATIENT STATUS IS ALI
Patient problems: Patient Problem/Medical Problem
MAUDE report 7532528 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page